<DOC>
	<DOC>NCT01902615</DOC>
	<brief_summary>This multicenter, retrospective, observational study will evaluate the therapeutic effectiveness of a strategy of induction with Fuzeon (enfuvirtide) within an optimized regimen of antiretroviral drugs in patients with HIV-1 infection in routine clinical practice.</brief_summary>
	<brief_title>An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Enfuvirtide</mesh_term>
	<criteria>Adult patients, &gt;/= 18 years of age HIV1+ infection Patients with a viral load &gt; 50 copies/ml who have received induction treatment with Fuzeon in combination with antiretroviral treatment Na√Øve for Fuzeon at initiation of induction treatment Antiretroviral treatment of at least 12 months duration Patients who did not receive Fuzeon treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>